Pricing Log in Create free account

NewcelX Ltd. (NCEL) vs Psyence Biomedical Ltd. (PBM)

NewcelX Ltd. and Psyence Biomedical Ltd. are both Biotechnology companies. NewcelX Ltd. and Psyence Biomedical Ltd. are of similar size ($16.5M and $15.3M). NewcelX Ltd. has negative trailing earnings, so its P/E is not meaningful; Psyence Biomedical Ltd. trades at 0.2×. Across the 9 metrics below, NewcelX Ltd. leads on 5 and Psyence Biomedical Ltd. on 4.

Valuation

Metric NCEL PBM Biotechnology median
P/E n/m 0.19 8.50
P/S n/m n/m 9.71
P/B 4.61 0.08 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m 1.82 0.64
EV/Sales n/m n/m 9.21
Earnings yield (61.20%) 534.77% (33.15%)
Free cash flow yield (17.60%) (807.70%) (25.50%)

Profitability

Metric NCEL PBM Biotechnology median
Gross margin 0.00% — 65.16%
Operating margin — — 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% (23.52%) (56.36%)
Return on assets 0.00% (6.74%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric NCEL PBM Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) 11.18% (138.35%) 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric NCEL PBM Biotechnology median
Debt to equity 0.06 0.00 0.00
Current ratio 0.40 8.09 4.72
Net debt to EBITDA 0.74 1.20 0.96

Dividend

Metric NCEL PBM Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric NCEL PBM Biotechnology median
Market cap 15.34m 16.47m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack